Kristin J. Lastwika, Ph.D.
Affiliations: | 2014 | Biomedical Sciences | The George Washington University, Washington, DC, United States |
Area:
Molecular Biology, Microbiology, SystematicGoogle:
"Kristin Lastwika"Parents
Sign in to add mentorDavid Leitenberg | grad student | 2014 | The George Washington University | |
(Regulation and Consequences of PD-L1 Expression in Non-Small Cell Lung Cancer.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Lastwika KJ, Kargl J, Zhang Y, et al. (2018) Tumor-Derived Autoantibodies Identify Malignant Pulmonary Nodules. American Journal of Respiratory and Critical Care Medicine |
Lastwika KJ, Wilson W, Li QK, et al. (2015) Control of PD-L1 expression by oncogenic activation of the AKT/mTOR pathway in non-small cell lung cancer. Cancer Research |
Robinson GL, Robinson JP, Lastwika KJ, et al. (2013) Akt signaling accelerates tumor recurrence following ras inhibition in the context of ink4a/arf loss. Genes & Cancer. 4: 476-85 |
Lastwika K, Wilson W, Dennis PA. (2013) Abstract 4981: PI3K/AKT/mTOR pathway activation drives expression of the immune inhibitory ligand PD-L1 in NSCLC. Cancer Research. 73: 4981-4981 |
Robinson JP, Vanbrocklin MW, Lastwika KJ, et al. (2011) Activated MEK cooperates with Ink4a/Arf loss or Akt activation to induce gliomas in vivo. Oncogene. 30: 1341-50 |